Evidence map›Paper›PMID 11748274›Full record

ArticleThe Journal of experimental medicine2001

Homeostatic competition among T cells revealed by conditional inactivation of the mouse Cd4 gene.

Q Wang, J Strong, N Killeen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Protein Phosphatase 2A Promotes CD8Research (Washington, D.C.) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Immune checkpoint inhibitors unleash pathogenic immune responses against the microbiota.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. DistalImmunoHorizons · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Q WangDepartment of Microbiology and Immunology, University of California at San Francisco, San Francisco, CA 94143-0414, USA.
J Strong
N Killeen
University of California, San Francisco · US

Funding

Selection of the T Cell Receptor RepertoireR01AI039506 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KILLEEN, NIGEL PATRICK · 1997 to 2006
$1.8M
NIAID NIH HHS R01 AI039506NIAID NIH HHS R01 AI39506
6 · The paper itself

Abstract

Absence of CD4 impairs the efficiency of T cell receptor (TCR) signaling in response to major histocompatibility complex (MHC) class II-presented peptides. Here we use mice carrying a conditional Cd4 allele to study the consequences of impaired TCR signaling after the completion of thymocyte development. We show that loss of CD4 decreases the steady-state proliferation of T cells as monitored by in vivo labeling with bromo-deoxyuridine. Moreover, T cells lacking CD4 compete poorly with CD4-expressing T cells during proliferative expansion after transfer into lymphopenic recipients. The data suggest that T cells compete with one another during homeostatic proliferation, and indicate that the basis of this competition is TCR signaling.

Indexed as

CD4 AntigensSignal TransductionAnimalsCD4-Positive T-LymphocytesCell DifferentiationFemaleHumansMajor Histocompatibility ComplexMaleMiceMice, Inbred C57BLMice, TransgenicMutationReceptors, Antigen, T-CellCD4 AntigensReceptors, Antigen, T-Cell

Identifiers

PMID11748274
PMCPMC2193581
OpenAlexW2135575803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.